- Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Analysis for Diabetic Gastroparesis Patients Treated with GIMOTI® Versus Oral Metoclopramide at the Digestive Disease Week Plenary Session Feb 23 SOLANA BEACH, Calif., and CHICAGO, IL., February 21, 2023 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty... read more
- Spotlight: Corporate Member of the Month, February 2023 Feb 20 NASP is pleased to shine a bright light this week on Perigon Pharmacy 360, the third... read more
- Spotlight: Corporate Member of the Month, February 2023 Feb 13 NASP is pleased to shine a bright light this week on Genentech, the second corporate member... read more
- Spotlight: Corporate Member of the Month, February 2023 Feb 06 NASP is pleased to shine a bright light this week on Shipment Trackers, the first corporate... read more
- Spotlight: Corporate Members of the Month, February 2023 Feb 01 NASP is pleased to announce the February Spotlight: NASP Corporate Members of the Month! This month, we’ll... read more
- Spotlight: Corporate Member of the Month, January 2023 Jan 30 NASP is pleased to shine a bright light this week on Optum Frontier Therapies, the fourth... read more
- Spotlight: Corporate Member of the Month, January 2023 Jan 23 NASP is pleased to shine a bright light this week on Patient Access Network (PAN) Foundation,... read more
- Acentrus Specialty Partners with ParcelShield Jan 17 Acentrus Specialty Partners with ParcelShield To improve healthcare quality for millions of patients with predictive on-time... read more
- Spotlight: Corporate Member of the Month, January 2023 Jan 16 NASP is pleased to shine a bright light this week on Mirati Therapeutics, the second corporate... read more
- Spotlight: Corporate Member of the Month, January 2023 Jan 09 NASP is pleased to shine a bright light this week on Beth Israel Lahey Health (BILH)... read more